Evidence map›Paper›PMID 40332568›Full record

ArticleEuropean radiology2025

Multicollinearity and redundancy of the PET radiomic feature set.

Wyanne A Noortman, Dennis Vriens, Johan Bussink, Tineke W H Meijer, Erik H J G Aarntzen, Christophe M Deroose, Renaud Lhommel, Nicolas Aide, Christophe Le Tourneau, Elizabeth J de Koster and 6 more

Abstract read
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. CT radiomics showed no improvement beyond volume dynamics for early lesion-level size response to immunotherapy in metastatic melanoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wyanne A NoortmanDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands. w.a.noortman@umcg.nl.ORCID http://orcid.org/0000-0003-0450-951X
Dennis VriensDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Johan BussinkDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Tineke W H MeijerDepartment of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Erik H J G AarntzenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Christophe M DerooseNuclear Medicine, UZ Leuven, Leuven, Belgium.
Renaud LhommelDivision of Nuclear Medicine and Institut de Recherche Clinique, Cliniques Universitaires Saint Luc (UCLouvain), Brussels, Belgium.
Nicolas AideINSERM ANTICIPE U1086, François Baclesse Cancer Centre, Caen, France.
Christophe Le TourneauDepartment of Drug Development and Innovation, Institut Curie, Paris-Saclay University, Paris, France.
Elizabeth J de KosterDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Wim J G OyenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Lianne TriemstraDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Jelle P RuurdaDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Erik VegtDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Lioe-Fee de Geus-OeiDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Floris H P van VeldenDepartment of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to map multicollinearity of the radiomic feature set in five independent [

methodsFive [

resultsSeventy-two and 90 out of 105 features showed a (very) strong correlation with another feature in the correlation matrix in all five cohorts. Cluster analysis resulted in 35 and 15 non-redundant features at thresholds of ρ = 0.9 and ρ = 0.7, including 6 and 3 shape features, 4 and 2 intensity features, and 25 and 10 texture features, respectively. Seventy or 90 redundant features could be omitted at these thresholds, respectively.

conclusionAt least two-thirds of the radiomic feature set could be omitted because of strong multicollinearity in multiple independent cohorts. More redundant features could be identified using a less conservative threshold. Future research should indicate whether multicollinearity of the radiomic feature set is similar for other radiopharmaceuticals and imaging modalities. KEY POINTS: Question Radiomic feature sets contain many strongly correlating features, which results in statistical challenges. Findings Analysis of the correlation matrices showed that the same radiomic features were strongly correlated in five independent [

Indexed as

Positron-Emission TomographyAdultAgedCarcinoma, Non-Small-Cell LungCohort StudiesFemaleFluorodeoxyglucose F18Head and Neck NeoplasmsHumansLung NeoplasmsMaleMiddle AgedPheochromocytomaRadiomicsRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsFeature reductionMalignanciesMulticollinearityPET-CTRadiomics

Identifiers

PMID40332568
PMCPMC12559118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.